New Delhi, April 1 GLP-1-based weight loss drugs are prescription medications used to treat type 2 diabetes and obesity, but they carry serious side effects and must only be taken under the supervision of a qualified medical specialist, the government said on Wednesday.Highlighting that...
New Delhi, March 24 To ensure ethical pharmaceutical practices in the supply chain of weight-loss drugs of the GLP-1 class, the Drugs Controller General of India (DCGI) has intensified its regulatory surveillance against the unauthorized sale and promotion of the medications.To this end...